Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma

Objective: Circulating free DNA (cfDNA) in general and circulating tumor DNA (ctDNA) in particular is becoming an increasingly used form of liquid biopsy biomarkers. In this study, we are investigating the ability to detect ctDNA from the plasma of pituitary adenoma (PA) patients. Design: Tumor tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Megnis, Kaspars, Peculis, Raitis, Rovite, Vita, Laksa, Pola, Niedra, Helvijs, Balcere, Inga, Caune, Olivija, Breiksa, Austra, Nazarovs, Jurijs, Stukens, Janis, Konrade, Ilze, Pirags, Valdis, Klovins, Janis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759656/
https://www.ncbi.nlm.nih.gov/pubmed/31620080
http://dx.doi.org/10.3389/fendo.2019.00615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759656/
https://www.ncbi.nlm.nih.gov/pubmed/31620080
http://dx.doi.org/10.3389/fendo.2019.00615

Ejemplares similares